HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...